Childhood Obesity and Metabolic Research
While the consequences of obesity are generally recognized in adulthood, the pathogenic processes that lead to obesity and its complications are effective considerably earlier in childhood. We have shown that early childhood is a vulnerable age for the development of obesity, which is sustained into adulthood. Moreover, our research demonstrated that even in children, obesity is already linked to emerging cardiometabolic dysfunction, which is closely associated with alterations in adipose tissue biology.
Our research group focuses on the origins, mechanisms, and consequences of childhood obesity and metabolic deterioration. We place particular emphasis on the early development of metabolic complications and the role of adipose tissue function, employing a holistic translational approach that integrates experimental research with epidemiological, clinical, and genetic studies. We develop novel and more precise risk detection and implement trials on novel treatment opportunities.
Our overarching goal is to address childhood obesity by advancing our understanding of its epidemiological and clinical correlations, underlying mechanisms - with a special focus on adipose tissue dysfunction - and the interplay of genetic and environmental risk factors. Through this deeper insight, we aim to identify novel targets for prevention and therapeutic intervention.
While the consequences of obesity are generally recognized in adulthood, the pathogenic processes that lead to obesity and its complications are effective considerably earlier in childhood. We have shown that early childhood is a vulnerable age for the development of obesity, which is sustained into adulthood. Moreover, our research demonstrated that even in children, obesity is already linked to emerging cardiometabolic dysfunction, which is closely associated with alterations in adipose tissue biology.
Our research group focuses on the origins, mechanisms, and consequences of childhood obesity and metabolic deterioration. We place particular emphasis on the early development of metabolic complications and the role of adipose tissue function, employing a holistic translational approach that integrates experimental research with epidemiological, clinical, and genetic studies. We develop novel and more precise risk detection and implement trials on novel treatment opportunities.
Our overarching goal is to address childhood obesity by advancing our understanding of its epidemiological and clinical correlations, underlying mechanisms - with a special focus on adipose tissue dysfunction - and the interplay of genetic and environmental risk factors. Through this deeper insight, we aim to identify novel targets for prevention and therapeutic intervention.